Condition (MeSH)
Virilism
ClinicalTrials.gov lists 40 trials for Virilism or a narrower condition beneath it. Corcept Therapeutics has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
When did Virilism trials start? (21)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 3 |
| 2023 | 3 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 1 |
Showing 10 of 21 earlier years.
No forecast is made for this condition: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Virilism trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 1/2 | 2 |
| Phase 2 | 2 |
| Phase 2/3 | 1 |
| Phase 3 | 2 |
| Phase 4 | 5 |
| Not applicable | 11 |
| Observational | 14 |
How many Virilism trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 19 |
| Suspended | 1 |
| Terminated | 4 |
| Unknown status | 10 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Virilism trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Corcept Therapeutics | 3 |
| Sandoz | 2 |
| Scilex Ltd. | 2 |
| Alexander Shayesteh | 1 |
| Allergan | 1 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Virilism? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Mifepristone | 2 |
| Eflornithine | 2 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA) | 2 |
| 1% Metformin | 2 |
| triglycerides (Intralipid 20%) | 1 |
| myo-inositol 2000 gr + folic acid 200 mcg | 1 |
| GLIDE | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Virilism trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Blood Postassium Decreased | 4 | 1 |
| Adrenal Insufficiency | 3 | 2 |
| Respiratory Failure | 3 | 2 |
| Dyspnoea | 2 | 2 |
| Pneumonia | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Virilism? (13)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS). | The Journal of clinical endocrinology and metabolism | 2013 | Yes |
| Postmenopausal virilization after spousal use of topical androgens. | Fertility and sterility | 2007 | Yes |
| Children's virilization and the use of a testosterone gel by their fathers. | European journal of pediatrics | 2005 | Yes |
| Virilization of young children after topical androgen use by their parents. | Pediatrics | 2004 | Yes |
| Risks of menopausal androgen supplementation. | Seminars in reproductive endocrinology | 1998 | Yes |
Showing 5 of 13 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.